AI English summary of an SEC filing — figures as filed
HCA Healthcare HCAThe company said its Compensation Committee adopted the 2024 Executive Officer Performance Excellence Program on February 22, 2024. Executive officer performance award opportunities are weighted 80% on achievement of EBITDA targets and 20% on achievement of quality metric targets.
Key points
AI summaryThe company said its Compensation Committee adopted the 2024 Executive Officer Performance Excellence Program on February 22, 2024. Executive officer performance award opportunities are weighted 80% on achievement of EBITDA targets and 20% on achievement of quality metric targets.
The company set target Executive Officer PEP award opportunities for 2024 at 170% of base salary for Samuel N. Hazen, its chief executive officer; 125% for Jon M. Foster, its chief operating officer; and 85% for Michael R. McAlevey. McAlevey's percentage is scheduled to increase to 100% from April 1, 2024.
The company said participants will receive 25% of the EBITDA-weighted target award at threshold performance, 100% at target performance and up to 200% at maximum performance. If actual EBITDA is below 90% of target EBITDA, no quality-weighted portion will be paid. Awards will be paid entirely in cash.
The company said its board appointed Michael R. McAlevey as Executive Vice President – Chief Legal and Administrative Officer effective April 1, 2024, and its Compensation Committee approved a base salary of $990,000. A long-term equity award with a target grant date value of $500,000 is expected to be granted in late April 2024.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
2024 Executive Officer Performance Program Weightings
The company said its Compensation Committee adopted the 2024 Executive Officer Performance Excellence Program on February 22, 2024. Executive officer performance award opportunities are weighted 80% on achievement of EBITDA targets and 20% on achievement of quality metric targets.
Source · Based on the filing body and exhibits
Target Incentive Opportunities for the CEO and Other Executives
The company set target Executive Officer PEP award opportunities for 2024 at 170% of base salary for Samuel N. Hazen, its chief executive officer; 125% for Jon M. Foster, its chief operating officer; and 85% for Michael R. McAlevey. McAlevey's percentage is scheduled to increase to 100% from April 1, 2024.
Source · Based on the filing body and exhibits
Payout Ranges for the EBITDA Portion and Conditions for the Quality Portion
The company said participants will receive 25% of the EBITDA-weighted target award at threshold performance, 100% at target performance and up to 200% at maximum performance. If actual EBITDA is below 90% of target EBITDA, no quality-weighted portion will be paid. Awards will be paid entirely in cash.
Source · Based on the filing body and exhibits
Base Salary and Equity Compensation for McAlevey's New Role
The company said its board appointed Michael R. McAlevey as Executive Vice President – Chief Legal and Administrative Officer effective April 1, 2024, and its Compensation Committee approved a base salary of $990,000. A long-term equity award with a target grant date value of $500,000 is expected to be granted in late April 2024.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…